For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| 200 mg Lasmiditan | Lasmiditan administered orally, alone | 0 | None | 0 | 20 | 8 | 20 | View |
| Placebo | Placebo administered orally, alone | 0 | None | 0 | 10 | 3 | 10 | View |
| Topiramate Alone | Topiramate administered orally, alone | 0 | None | 0 | 30 | 5 | 30 | View |
| 50 mg Topiramate + 200 mg Lasmiditan | Topiramate administered orally, alone, and co-administered with oral lasmiditan | 0 | None | 0 | 20 | 8 | 20 | View |
| 50 mg Topiramate + Placebo | Topiramate administered orally, alone, and co-administered with oral placebo | 0 | None | 0 | 10 | 2 | 10 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Lip dry | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDRA 20.0 | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | MedDRA 20.0 | View |
| Scratch | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDRA 20.0 | View |
| Disturbance in attention | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 20.0 | View |
| Dizziness | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 20.0 | View |
| Somnolence | SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDRA 20.0 | View |
| Depressed mood | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 20.0 | View |
| Euphoric mood | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDRA 20.0 | View |